Skip Navigation

European Heart Journal 1996 17(12):1867-1874;
Copyright © 1996 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dormans, T. P. J.
Right arrow Articles by Gerlag, P. G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dormans, T. P. J.
Right arrow Articles by Gerlag, P. G. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 The European Society of Cardiology

Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure

T. P. J. Dormans and P. G. G. Gerlag*

Department of Internal Medicine, University Hospital Nijmegen, The Netherlands
*Department of Internal Medicine, St Joseph Hospital Veldhoven, The Netherlands

Received 23 February 1996; accepted 28 February 1996.

Correspondence: Tom Dormans, Department of Internal Medicine, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Abstract

OBJECTIVE: We studied the synergism between high-dose furosemide and hydrochlorothiazide in patients with severe congestive heart failure and impaired renal function showing diuretic resistance to a daily dose of furosemide of at least 250 mg.

DESIGN AND SETTING: An open study A general hospital in The Netherlands.

METHODS: In 20 patients with severe congestive heart failure (stage III–IV according to the New York Heart Association) with an oedematous mass of more than 5 kg and a proven diuretic resistance to high-dose furosemide, hydrochlorothiazide (25–100 mg daily) was added to the medication for 3–12 days, leaving the other medication unchanged. After correction of the hydration state, hydrochlorothiazide was withdrawn. Variables included body weight, serum electrolytes, renal function and natriuresis.

RESULTS: Addition of hydrochlorothiazide resulted in a mean (± standard deviation) body weight reduction of 6.7 ± 3.3 kg per patient. Mean daily urine volume increased from 1899 ± 958 ml to 3065 ± 925 ml (P<0.001). Fractional sodium excretion increased significantly from 3.5 ± 3.2% to 11.5 ± 9.0% (P<0.001). The most important side effect of this combination therapy appeared to be hypokalaemia. Mean endogenous creatinine clearance decreased (not significantly) from 32.7 ± 22.5 ml . min–1 . 1.73 m–2 to 27.6 ± 22.5 ml . min–1. 1.73 m–2

CONCLUSIONS: Addition of hydrochlorothiazide to high-dose furosemide is a powerful diuretic tool, even in patients with a significantly reduced renal function. Because of its potentially dangerous side effects (hypokalaemia), it should be used in a carefully controlled setting.

Key Words: Diuretics • diuretic resistance • oedema • furosemide • heart failure • hydrochlorothiazide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
C. Libetta, V. Sepe, M. Zucchi, P. Pisacco, L. Cosmai, F. Meloni, C. Campana, T. Rampino, C. Monti, L. Tavazzi, et al.
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2013 - 2019.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Paterna, P. Di Pasquale, G. Parrinello, E. Fornaciari, F. Di Gaudio, S. Fasullo, M. Giammanco, F. M. Sarullo, and G. Licata
Changes in Brain Natriuretic Peptide Levels and Bioelectrical Impedance Measurements After Treatment With High-Dose Furosemide and Hypertonic Saline Solution Versus High-Dose Furosemide Alone in Refractory Congestive Heart Failure: A Double-Blind Study
J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1997 - 2003.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S U Shah, S Anjum, and W A Littler
Use of diuretics in cardiovascular diseases: (1) heart failure
Postgrad. Med. J., April 1, 2004; 80(942): 201 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
L K M De Bruyne
Mechanisms and management of diuretic resistance in congestive heart failure
Postgrad. Med. J., May 1, 2003; 79(931): 268 - 271.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. R. Kalra, C. Anagnostopoulos, A. P. Bolger, A. J. S. Coats, and S. D. Anker
The regulation and measurement of plasma volume in heart failure
J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1901 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Gellai, G. F. Schreiner, R. R. Ruffolo Jr., T. Fletcher, R. DeWolf, and D. P. Brooks
CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1191 - 1196.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.